Gender-specific abnormalities in the serotonin transporter system in panic disorder

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• The central serotonergic system is implicated in panic disorder (PD) pathophysiology.
• Evidence includes altered serotonin turnover, receptor sensitivity, and treatment response to serotonergic agents.
• Genetic factors influencing serotonin neurotransmission may increase PD vulnerability, particularly in males.

Purpose of the Study:

• To investigate elevated serotonin transporter (5-HTT) binding in PD patients compared to controls.
• To examine if 5-HTT binding differences are gender-dependent.
• To explore these findings in brain regions with known serotonergic involvement in PD.

Main Methods:

• Positron emission tomography (PET) with [(11)C]DASB was used to measure 5-HTT binding-potential (BP(ND)).
• Participants included out-patients with current PD (n=24) and healthy controls (n=24).
• PD severity was assessed using the PD Severity Scale.

Main Results:

• Males with PD showed increased 5-HTT BP(ND) in the anterior cingulate cortex and midbrain compared to male controls.
• No significant differences in 5-HTT BP(ND) were found between females with PD and female controls.
• These gender-specific findings suggest a sexual dimorphism in PD's serotonergic system dysfunction.

Conclusions:

• Elevated 5-HTT binding in males with PD supports central serotonergic system dysfunction.
• The absence of this finding in females suggests gender influences PD pathophysiology.
• These results may explain the differential efficacy of SSRI treatments observed between genders in PD.